Skip to main content

News & Press Releases

Filter by:

FDA Chair Bethany Hills and ML Strategies Senior Director Aaron Josephson are quoted in this article discussing the possibility of FDA Principal Deputy Commissioner Amy Abernethy filling in as acting FDA commissioner, or possibly even succeed FDA Commissioner Scott Gottlieb when the current commissioner leaves the agency in a month.

This article previews what may be said of health care in the 2019 State of the Union address. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor in Washington, provides commentary in the piece.

Health care industry insiders notes that the actions that Congress decides to take on health care in 2019 will largely be for show. Veteran health care policy advisor Rodney Whitlock, a Vice President with ML Strategies, is among those sources providing commentary in the piece.

This feature article discusses the potential constitutionality of the Affordable Care Act (ACA) and how we could not know the final verdict for years to come. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor in Washington, provides commentary in the piece.

Why Republicans (secretly) want the ACA to survive

December 19, 2018 | Washington Post

This Washington Post article discusses how a recent Texas judge’s decision finding the Affordable Care Act unconstitutional could impact Republicans in the House and Senate in the next Congress, as well as throughout the next election cycle. ML Strategies Vice President Rodney Whitlock, a veteran health care policy advisor, is quoted in the piece.

FDA Clarifies Breakthrough Device Pathway, Safer Tech Program

December 18, 2018 | Inside Health Policy

FDA Chair Bethany Hills and ML Strategies Senior Director Aaron Josephson are featured in this article discussing two recently-announced actions by the Food & Drug Administration (FDA) to encourage industry adoption of two accelerated review and development pathways for new devices. The FDA’s announcement centered upon a final guidance on the breakthrough devices pathway and recommendations for a new Safer Technologies Program (STeP).

Follow ML Strategies